BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 186168)

  • 1. Nasopharyngeal carcinoma and Burkitt's lymphoma in a Canadian family. I. HLA typing, EBV antibodies and serum immunoglobulins.
    Joncas JH; Rioux E; Wastiaux JP; Leyritz M; Robillard L; Menezes J
    Can Med Assoc J; 1976 Nov; 115(9):858-60. PubMed ID: 186168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple cases of lymphoepithelioma and Burkitt's lymphoma in a Canadian family.
    Joncas JH; Rioux E; Robitaille R; Wastiaux JP
    Bibl Haematol; 1975 Oct; (43):224-6. PubMed ID: 183675
    [No Abstract]   [Full Text] [Related]  

  • 3. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
    Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
    Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
    Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
    Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cluster of Epstein-Barr-virus-associated American Burkitt's lymphoma.
    Judson SC; Henle W; Henle G
    N Engl J Med; 1977 Sep; 297(9):464-8. PubMed ID: 196197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr Virus (EBV) in Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W; Henle G
    Ann Clin Lab Sci; 1974; 4(2):109-14. PubMed ID: 4362218
    [No Abstract]   [Full Text] [Related]  

  • 7. [Titer of antibodies against Burkitt's lymphoma virus in Burkitt's lymphoma and other diseases].
    Gunven P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):228-32. PubMed ID: 4353758
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
    Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
    Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactivity of radioiodinated serum antibody from Burkitt's lymphoma and nasopharyngeal carcinoma patients against culture lines derived from Bukrkitt's lymphoma.
    Inoue M; Klein G
    Clin Exp Immunol; 1970 Jul; 7(1):39-50. PubMed ID: 4320551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus encoded BALF1 gene is transcribed in Burkitt's lymphoma cell lines and in nasopharyngeal carcinoma's biopsies.
    Cabras G; Decaussin G; Zeng Y; Djennaoui D; Melouli H; Broully P; Bouguermouh AM; Ooka T
    J Clin Virol; 2005 Sep; 34(1):26-34. PubMed ID: 16087121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated Burkitt's lymphoma in India.
    Venkitaraman AR; John TJ; Rangad F; Singh AD; Date A; Lenoir G
    Trop Geogr Med; 1983 Sep; 35(3):273-7. PubMed ID: 6316592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epstein-Barr virus associated Burkitt's lymphoma in a French child (author's transl)].
    Lenoir G; Philip T; Bornkamm GW; Gillet P; Bryon PA; Bouvier R; Dodat H; Doré JF; Brunat-Mentigny M; Hermier M
    Nouv Presse Med; 1979 Dec; 8(49):4031-3. PubMed ID: 93275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas].
    Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T
    Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma.
    Klein G
    Isr J Med Sci; 1977 Jul; 13(7):716-24. PubMed ID: 200586
    [No Abstract]   [Full Text] [Related]  

  • 17. Burkitt's lymphoma cell line bearing surface IgA and negative for nuclear antigen of Epstein-Barr virus (EBNA).
    Hayashi Y; Matsumura Y; Nishihira T; Watanabe I; Ohi R; Kasai M; Kumagai K; Kamada N
    Jpn J Exp Med; 1980 Dec; 50(6):423-34. PubMed ID: 6268866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus and Burkitt's lymphoma.
    Magrath I; Jain V; Bhatia K
    Semin Cancer Biol; 1992 Oct; 3(5):285-95. PubMed ID: 1335792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EB virus-associated tumors-opportunistic B cell lymphoma, Burkitt's lymphoma, nasopharyngeal carcinoma].
    Mizuno F
    Nihon Rinsho; 1989 Feb; 47(2):481-6. PubMed ID: 2542671
    [No Abstract]   [Full Text] [Related]  

  • 20. Humoral immune response in Epstein-Barr virus infections. II. IgG subclass distribution in African patients with Burkitt's lymphoma and nasopharyngeal carcinoma.
    Kaschka WP; Klein G; Hilgers R; Skvaril F
    Clin Exp Immunol; 1984 Jan; 55(1):14-22. PubMed ID: 6319056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.